NICE Conference 2026 speakers
Prof Jonathan Benger CBE
Chief executive, NICE
Dr Clare Morgan
Director of impact and partnerships, NICE
Richard Vize
Journalist and public policy analyst and NICE Conference 2026 chair
Prof Matthew Ashton
Director of public health, Liverpool City Council
Kiran Bali MBE JP
Lay member, NICE medical technologies advisory committee
Dr Jacoline Bouvy
Deputy director of medicines evaluation, NICE
Malcolm Canvin
Head of product, NICE
Dr Mark Chavravarty
Non-executive director, NICE
Dr Nick Crabb
Chief scientific officer, NICE
Ross Dent
Associate director - medicines evaluation, NICE
Dr Louise Edwards
Programme director - implementation and insights, NICE
Sarah Fishburn
NICE guideline committee chair
Lesley Goodburn
Head of public involvement and engagement, NICE
Dr Amrita Jesurasa
National lead for prevention in clinical settings, Public Health Wales
Helen Knight
Director of medicines evaluation, NICE
Sarah Le Brocq
Founder and director, All About Obesity
Prof Ewan Maule
Chief pharmacist and director of medicines and pharmacy, North East and North Cumbria ICB
Dr Nicole Mittmann PhD
Chief scientist and vice-president of evidence editor-in-chief, Canadian Journal of Health Technologies, Canadian Drug Agency (CDA)
Paul Naish
Head of market access UK and Ireland, Sanofi
Prof Habib Naqvi
Chief executive of the NHS Race and Health Observatory
Daniel A. Ollendorf, PhD, MPH
Chief scientific officer and director of health technology assessment (HTA) methods and engagement, Institute for Clinical and Economic Review (ICER)
Angela Osei
Associate director – national implementation, NICE
Dr John Patterson
GP clinical advisor, NICE
Dr Keith Ridge CBE FRPharmS
Non-executive director, NICE
Mark Sculpher
Professor and director of the Centre for Health Economics, University of York
Dr Leila Shepherd
Managing director, Helix Centre, Institute of Global Health Innovation at Imperial College London
Thomas Slater
Director of healthtech and NICE Advice, NICE
John Spoors
Programme director - commercial, managed access and medicines policy, NICE
Lawrence Tallon
Chief executive, Medicines and Healthcare products Regulatory Agency (MHRA)
Dominic Wake
Head of corporate affairs, Sandoz Nordics
Dr Kay Nolan
Head of prioritisation and surveillance, NICE
Dr Scott Purdon
Head of patient advocacy, Myeloma UK and chair of the Charity Medicines Access Coalition (CMAC)
Mark Rasburn
Senior public involvement adviser, NICE
Aimee Robson
Deputy director primary and community care, improvement and development, NHS England
Shaun Rowark
Associate director - data access and analysis, NICE
Chris Sampson
Senior principal economist, Office of Health Economics
Dr Koonal Shah
Associate director – science policy and research, NICE
Prof Reecha Sofat
Breckenridge chair in clinical pharmacology and therapeutics, University of Liverpool
Luella Trickett
Executive director, medical devices, value and access, Association of British HealthTech Industries (ABHI)
Prof Clare Turnbull PhD FFPH FRCP FRCPath MPH-Epidemiology
Professor of cancer genetics, Institute of Cancer Research London and NHS consultant in clinical cancer genetics (Honorary), Royal Marsden NHS Foundation Trust
Philip Varghese FRCS MS MEd
Consultant colorectal surgeon minimally invasive and robotic colorectal surgery, University Hospitals of North Midlands NHS Trust
Bernadette Warren
Patient and NICE committee member